Wedbush cuts Beam Therapeutics price target to $28 from $65
Valid market news retained in the public archive without immediate LiveCast distribution.
Related stories
Fino Payments Bank Reports Q2 Net Loss of 209 Million Rupees
M impact | EQUITY | Oct 29, 2026, 01:59 PM UTC
Poundland Files Administration Notice as It Seeks Rescue Deal
The British discount retailer filed a notice of intention to appoint administrators, giving it temporary legal protection while it seeks a rescue deal.
M impact | EQUITY | Oct 29, 2026, 01:59 PM UTC
Poundland Files Administration Notice to Seek Rescue
UK retailer Poundland filed an administration notice to buy time for a rescue.
M impact | EQUITY | Oct 29, 2026, 01:59 PM UTC
Merck Raises Annual Profit Forecast After Topping Q3 Results
Merck shares rose after the company raised its annual profit forecast and reported Q3 results that topped expectations.
M impact | EQUITY | Oct 29, 2026, 01:59 PM UTC
Butterfly Network Q3 Loss Narrows, Revenue Rises; 2026 Outlook Raised
Butterfly Network reported a narrower adjusted loss and higher revenue in Q3, and raised its 2026 revenue outlook.
M impact | EQUITY | Oct 29, 2026, 01:58 PM UTC
Angang Steel Reports Q3 Net Loss of 2.0 Billion Yuan
M impact | EQUITY | Oct 29, 2026, 01:58 PM UTC